Another study in the 5xFAD AD murine model, using microglia-depletion strategies with long-term high doses of a CSF1R inhibitor (PLX3397), showed that microglial depletion prior to plaque formation is sufficient to prevent the onset of plaque pathology. The gene discussed is CSF1R; the disease is Alzheimer disease.